H–1Bs for Physicians and the Healthcare Workforce Act
Summary
HR7961 exempts H-1B healthcare workers from a $100,000 fee and entry restriction, directly benefiting hospital operators and healthcare companies that rely on foreign talent. The bill is in early legislative stages but has 38 cosponsors, indicating bipartisan support. Key beneficiaries include HCA, UNH, JNJ, and ABT through reduced labor costs and improved staffing.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.HR7961 exempts H-1B healthcare workers from a $100,000 fee, reducing labor costs for hospitals and healthcare companies
- 2.No federal funding is involved — the bill removes a regulatory cost, directly improving margins for employers
- 3.HCA and UNH are the most directly impacted publicly traded companies due to their large physician workforces
- 4.The bill has 38 cosponsors but is in early legislative stage — passage is uncertain and likely not before 2027
Market Implications
The bill's impact is structural but gradual. Hospital operators like HCA ($HCA) and health insurers with provider networks like UNH stand to benefit from reduced labor costs if the bill passes. The exemption directly lowers the cost of hiring foreign physicians and nurses, which is a significant expense for these companies. However, the bill is in early stage and faces an uncertain path to law. Investors should monitor committee hearings and Senate companion bill introduction as key catalysts.
Full Analysis
-
What happened: On March 17, 2026, Rep. Lawler (R-NY) introduced HR7961, the H-1Bs for Physicians and the Healthcare Workforce Act. The bill was referred to the House Judiciary Committee. It has 38 cosponsors, including both Republicans and Democrats, suggesting moderate bipartisan support. The bill is in early stage with no further action since referral.
-
The money trail: This bill does not authorize or appropriate any federal funding. Instead, it removes a regulatory cost — the $100,000 fee imposed by a September 2025 Presidential Proclamation on H-1B visa holders. By exempting healthcare workers from this fee, the bill reduces hiring costs for healthcare employers. The savings flow directly to companies' bottom lines. No taxpayer funds are involved.
-
Structural winners: Hospital operators like HCA ($HCA) and health insurers with provider networks like UnitedHealth Group are primary beneficiaries as they directly employ foreign physicians and nurses. Medical device and pharmaceutical companies like Johnson & Johnson and Abbott Laboratories ($ABT) benefit from access to foreign researchers and clinical staff. The bill does not create new spending but reduces regulatory burden.
-
Competitive landscape: The bill levels the playing field for US healthcare employers competing for global talent. Companies with large hospital networks (HCA, UNH's Optum) gain the most as they face chronic staffing shortages. Smaller rural hospitals may benefit disproportionately but are not publicly traded. The bill does not affect drug pricing or insurance reimbursement.
-
Timeline: The bill is in early stage — referred to committee with no hearings scheduled. Passage probability is moderate given bipartisan cosponsorship but uncertain in a divided Congress. Next steps: committee markup, House floor vote, Senate companion bill (none yet), and presidential action. Timeline: unlikely to pass before 2027.
Intelligence Surface
Cross-referenced against federal contracts, SEC insider filings & congressional trade disclosures
No confirming evidence found yet from contracts, insider trades, or congressional activity
What the bill does
Exemption from $100,000 fee and entry restriction for H-1B healthcare workers
Who must act
HCA Healthcare and other hospital operators hiring foreign physicians and healthcare workers under H-1B visas
What happens
Reduced visa costs and increased supply of foreign healthcare workers, lowering labor costs and alleviating staffing shortages
Stock impact
HCA operates 186 hospitals and relies on foreign-trained physicians and nurses; the exemption directly reduces hiring costs and improves staffing stability, supporting patient volume and revenue
What the bill does
Exemption from $100,000 fee and entry restriction for H-1B healthcare workers
Who must act
Abbott Laboratories hiring foreign researchers and healthcare professionals for diagnostics and medical devices
What happens
Reduced visa costs and increased supply of foreign talent in R&D and clinical roles
Stock impact
Abbott's diagnostics and medical device divisions benefit from access to foreign scientists and engineers; the exemption reduces hiring costs and supports innovation
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Centers for Medicare & Medicaid Services of the Department of Health and Human Services relating to "Medicare Program; Implementation of Prior Authorization for Select Services for the Wasteful and Inappropriate Services Reduction (WISeR) Model".
Wildlife Health Coordination and Zoonotic Disease Prevention Act of 2026
Our Doctors First Act of 2026
Patients Deserve Price Tags Act
Health Marketplace and Savings Accounts for All Act
Charlotte Woodward Organ Transplant Discrimination Prevention Act
Medical Device Electronic Labeling Act
To amend the Internal Revenue Code of 1986 to limit eligibility for the premium tax credit to individuals enrolled in qualified health plans offered by health insurance issuers that offer at least one qualified health plan which provides the option to make monthly cost-sharing payments, and for other purposes.
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Advancing Regenerative Agriculture and Strengthening American Farm Resilience
This executive order directs the EPA, USDA, and HHS to prioritize registration of alternative pesticides, expedite cumulative exposure research, and maximize funding for a regenerative agriculture pilot program, while creating public-private partnerships to expand adoption of conservation farming practices. The order specifically instructs the EPA Administrator to speed up registration actions for substances that can replace older active ingredients, and requires HHS to issue a grand prize challenge for cumulative chemical exposure evaluation technologies.
Implementing Schedule Policy/Career in the Excepted Service
This executive order expands the Schedule Policy/Career excepted service category, transferring certain federal positions from competitive service to at-will employment to facilitate removal for poor performance or misconduct. It directs agency heads to petition for reclassification of policy-influencing roles, mandates performance bonus pools for these employees, and amends civil service rules to exempt them from standard adverse action procedures.
Realigning United States Core Childhood Vaccine Recommendations with Best Practices from Peer, Developed Countries
This executive order directs the CDC and ACIP to review and potentially update the U.S. childhood vaccine schedule to align with recommendations from peer developed countries, which recommend fewer vaccines. It maintains insurance coverage for all currently available vaccines without cost sharing and emphasizes protecting religious liberty and parental authority.
Free — no credit card
Get the next market-moving signal before the news does
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →